For much of the 2010s, Oracle (NYSE: ORCL) stock went nowhere as the legacy tech giant struggled to deliver growth and fell behind the faster growing tech stocks now known as the "Magnificent Seven." However,

If OpenAI LLC were a listed company, Monday would have been a very bad day for the stock. But Chief Executive Sam Altman also happens to be chairman of another, less well-known company that is listed,

Oracle ( ORCL ), fresh off of announcing its part in the massive Stargate Project alongside OpenAI and SoftBank, debuted its latest AI agents aimed at manufacturers during its CloudWorld event in Austin Thursday. Scott Bessent confirmed as Treasury secretary, giving him a key role in extending Trump's tax cuts

Parmy Olson is a Bloomberg Opinion columnist covering technology. A former reporter for the Wall Street Journal and Forbes, she is author of “Supremacy: AI, ChatGPT and the Race That Will Change the World.”

As Oracle (ORCL) joins the Stargate Project, a new $500B AI infrastructure initiative, are there risks to Microsoft (MSFT) - OpenAI partnership. Read more here.

Oracle stock took off as President Trump announced the Stargate AI infrastructure project. Read why I maintain my buy rating for ORCL stock.

President Donald Trump unveiled a $500 billion private joint venture to leapfrog U.S. dominance over artificial intelligence. Called Stargate, the project brings together Oracle (NASDAQ:ORCL), one of the world’s biggest data center operators,

Nuclear energy stocks roared higher Thursday, extending gains earlier in the week amid expectations of growing energy demand driven by AI after President Trump announced a $500 billion AI infrastructure project.

Oracle stock jumped 6% on a report that Trump plans to announce billions of dollars in private sector investment to build artificial intelligence infrastructure in the US.

San Francisco, Jan 23 (IANS) The xAI owner Elon Musk and OpenAI CEO Sam Altman are fighting on X about Stargate, the enormous infrastructure project to build data centres for OpenAI across the US.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.